Breast and ovarian cancer risk screening | Kailos
 
 

Knowing your risk for breast and ovarian cancer means you can take action

Women and men with certain variations in their DNA are at increased risk for developing breast cancer—and ovarian cancer in women. Getting tested can give you the information you and your doctor need to enhance your screening or take preventive action.

If you decide testing is the right thing to do, risk screening can be done for women and men as early as age 19—and at any age after that.

How Kailos can help you

With the Kailos test, you can tell if you carry BRCA1 and BRCA2 gene mutations, which are strong risk indicators for breast and ovarian cancer. Together, according to the CDC, BRCA1 and BRCA2 mutations account for 20% to 25% of hereditary breast cancers. The Kailos test will also test for changes in 30 additional genes, including APC, ATM, BARD1, BMPR1A, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, FLCN, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD50, RAD51C, RAD51D, RINT1, SDHB, SMAD4, STK11, TP53, VHL, and XRCC2, to inform you about risks associated with breast, ovarian, colon, and endometrial (uterine) cancers.

If you decide testing is the right thing to do, risk screening can be done for women and men as early as age 19—and at any age after that.

Cancer Screening, $225

Pre-test Counseling